Atopie

Atopic dermatitis is a chronic relapsing inflammat-ry skin disease that affects 15–20% of children and 2–10% of adults worldwide. Topical treatments in-clude corticosteroids and calcineurin inhibitors, de-spite frequently observed adverse events, such as skin atrophy, itching and burning sensations. Alternative treatments that can prolong disease relief between flare-upsare therefore needed. A randomized, single-blind, placebo-controlled, multicentre [...]